We found higher levels of exosomal miR-16 in ER- and PR-positive BC patients than in ER-, PR- and triple negative BC patients, as well as higher levels in BC patients with recurrence than in healthy women and DCIS patients. The gene discussed is ESR1; the disease is ductal breast carcinoma in situ.